Ribomic Inc (4591)

Currency in JPY
66.0
+2.0(+3.13%)
Closed·
Advertisement
4591 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
64.066.0
52 wk Range
57.0127.0
Key Statistics
Bid/Ask
65.00 / 66.00
Prev. Close
64
Open
65
Day's Range
64-66
52 wk Range
57-127
Volume
106.1K
Average Volume (3m)
535.38K
1-Year Change
-36.5385%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4591 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Ribomic Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
14/05/2026
EPS / Forecast
-7.21 / --
Revenue / Forecast
3M / --
EPS Revisions
Last 90 days

Compare 4591 to Peers and Sector

Metrics to compare
4591
Peers
Sector
Relationship
P/E Ratio
−3.2x−8.2x−0.4x
PEG Ratio
−0.38−0.200.00
Price/Book
1.3x3.1x2.6x
Price / LTM Sales
1,230.9x20.6x3.0x
Upside (Analyst Target)
-143.4%49.1%
Fair Value Upside
Unlock5.9%6.1%Unlock

Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. The company was incorporated in 2003 and is headquartered in Tokyo, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
2.79M4.99%184.25M
Public Companies & Retail Investors
53.16M95.01%3.51B
Total
55.95M100.00%3.69B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rakuten Investment Management, Inc.4.99%2,791,700184,252

FAQ

What Is the Ribomic (Tokyo: 4591) Share Price Today?

The Ribomic stock price today is 66.0 JPY.

What Stock Exchange Does Ribomic (4591) Trade On?

Ribomic is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for Ribomic?

The stock symbol (also called a 'ticker') for Ribomic is "4591."

What Is the Current Ribomic Market Capitalisation?

As of today, Ribomic (Tokyo: 4591) market cap is 3.69B JPY.

What Is Ribomic's (4591) Earnings Per Share (TTM)?

The Ribomic EPS is currently -23.1 (Trailing Twelve Months).

When Is the Next Ribomic Earnings Date?

Ribomic's next earnings report will be released on 06/08/2026.

Is 4591 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Ribomic moving averages and other technical indicators, the daily buy/sell signal for 4591 stock is Buy.

How Many Times Has Ribomic Stock Split?

Ribomic has split 0 times. (See the 4591 stock split history page for full effective split date and price information.)

How Many Employees Does Ribomic Have?

Ribomic has 25 employees, based on their latest Companies House report.

What is the current trading status of Ribomic (Tokyo: 4591)?

As of 04/07/2026, Ribomic (4591) is trading at a share price of 66.0 JPY, with a previous close of 64.0 JPY. The stock has fluctuated within a day range of 64.0 JPY to 66.0 JPY, while its 52-week range spans from 57.0 JPY to 127.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.